TA1 is approved in several countries for treating viral infections and has been used as an adjunct therapy in cancer and chronic hepatitis
In the brain, resistance is mainly characterized by disrupted signaling pathways, such as the PI3K/Akt pathway, rather than a primary issue with glucose transport, as neuronal glucose uptake is largely independent of insulin
While this study doesnt specifically look at eating disorders, it does suggest that people with eating disorders may be more likely to seek out GLP-1 medications
Immunity 57 , 513527.e516 (2024)
S2CID 11465789
KPV benefits include: Targets Inflammation Safely: Acts locally in the colon for direct symptom relief Improves Gut Integrity: Strengthens mucosal barriers and reduces leaky gut permeability Supports Long-Term Gut Health: Maintains immune balance without suppression Enhances Digestion: Improves nutrient absorption and bowel regularity Non-Toxic and Well-Tolerated: Suitable for ongoing therapy and preventive care Emerging studies from the National Institutes of Health suggest that KPV may reduce cytokine overproduction and inflammatory signaling, supporting its potential as a safe, effective anti-inflammatory therapy